Nuotio, Joel
Niiranen, Teemu
Laitinen, Tomi T.
Miller, Jessica
Sabin, Matthew A.
Havulinna, Aki S.
Viikari, Jorma S. A.
Rönnemaa, Tapani
Hutri-Kähönen, Nina
Laitinen, Tomi P.
Tossavainen, Päivi
Salomaa, Veikko
Raitakari, Olli T.
Burgner, David P.
Juonala, Markus
Article History
Received: 3 February 2022
Accepted: 2 November 2022
First Online: 18 November 2022
Declarations
:
: The Cardiovascular Risk in Young Finns Study has been approved by the Joint Commission on Ethics of the Turku University and the Turku University Central Hospital and has been conducted according to the guidelines of the Declaration of Helsinki. An informed written consent was obtained from the parents when participants were still under-aged and after reaching adulthood, from the participants themselves.The FINRISK study has obtained an ethical approval according to the Finnish legislation and common ethical requirements at the time of each survey: confidentiality, anonymity and data protection have been assured. A written informed consent has been obtained from each participant. Surveys have obtained permissions from the ethics committee which has varied over time. For the latest two surveys, in 2007 and 2012, the approval was obtained from the Coordinating Ethics Committee for the Helsinki and Uusimaa Hospital District.
: Not applicable.
: None. VS has consulted for Novo Nordisk and Sanofi and received honoraria from these companies. He also has ongoing research collaboration with Bayer Ag. (All unrelated to the present study).